I'm not new to the company but never have owned this stock. A friend of mine who day trades for a living told me to buy this back at around 5 in April of 2012. I opted not to because biotechs scare the #$%$ out of me. Anyway, I watched painfully as this stock went to 15 pretty quickly...Then I watched it come all the way down. It has been my experience that buying after offerings generally works well because there it eliminates the downside risk of a potential offering. This is probably going to run up a buck or 2 pretty quickly.
Biotech stocks go up and then they go down again.It is a cyclical wave.If you like a biotech stock like MDGN then wait till the price goes down to a 52 week low then buy in.Always give the stock time to recover.Eventually positive news will surface and the stock price rises.Then you take your profits.Even though the Hepatitis arena has competition from Big Pharma,there is always room for new ideas and technology.I love novel approaches.So I am a buyer of MDGN at or around $5.
i agree with a lot of what u said, except the 52 wk low, which i don't think you really agree with if you're a buyer at 5....the placement before this was done at 4.90 (and didn't trade close to that) so i do think we'll see a lot of support at that area). Besides working thru the offering, ppl are prob getting margin calls...also tomorrow the transaction closes, so that's a positive....i think it's as attractive as it's gonna get....time will tell